Serum anti-BPAG1 autoantibody level is not a useful biomarker for cutaneous melanoma.

Gambichler, Thilo

Serum anti-BPAG1 autoantibody level is not a useful biomarker for cutaneous melanoma. [electronic resource] - Melanoma research Feb 2016 - 88-9 p. digital

Publication Type: Letter

1473-5636

10.1097/CMR.0000000000000189 doi


Adult
Aged
Autoantibodies--blood
Biomarkers, Tumor--blood
Carrier Proteins--antagonists & inhibitors
Case-Control Studies
Cross-Sectional Studies
Cytoskeletal Proteins--antagonists & inhibitors
Dystonin
Female
Humans
Male
Melanoma--blood
Middle Aged
Nerve Tissue Proteins--antagonists & inhibitors
Predictive Value of Tests
Skin Neoplasms--blood
Young Adult